AJANTPHARM.BOAJANTPHARM.BOBSE
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank44
3Y CAGR-24.3%
5Y CAGR-19.4%
Year-over-Year Change
Year-over-year revenue growth rate
3Y CAGR
-24.3%/yr
vs -9.9%/yr prior
5Y CAGR
-19.4%/yr
Recent deceleration
Acceleration
-14.4pp
Decelerating
Percentile
P44
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | 1.56% |
| Q3 2025 | 3.92% |
| Q2 2025 | 11.30% |
| Q1 2025 | 2.12% |
| Q4 2024 | -3.41% |
| Q3 2024 | 3.64% |
| Q2 2024 | 8.62% |
| Q1 2024 | -4.62% |
| Q4 2023 | 7.46% |
| Q3 2023 | 0.72% |
| Q2 2023 | 15.79% |
| Q1 2023 | -9.25% |
| Q4 2022 | 3.59% |
| Q3 2022 | -1.35% |
| Q2 2022 | 16.90% |
| Q1 2022 | -2.92% |
| Q4 2021 | -5.30% |
| Q3 2021 | 18.29% |
| Q2 2021 | 4.74% |
| Q1 2021 | -4.62% |
| Q4 2020 | 4.59% |
| Q3 2020 | 7.14% |
| Q2 2020 | 1.88% |
| Q1 2020 | 0.72% |
| Q4 2019 | 1.31% |
| Q3 2019 | 5.04% |
| Q2 2019 | 28.49% |
| Q1 2019 | -1.83% |
| Q4 2018 | -10.84% |
| Q3 2018 | 6.48% |
| Q2 2018 | -3.64% |
| Q1 2018 | -9.67% |
| Q4 2017 | 8.64% |
| Q3 2017 | 14.22% |
| Q2 2017 | -0.77% |
| Q1 2017 | -10.56% |
| Q4 2016 | 3.35% |
| Q3 2016 | 9.51% |
| Q2 2016 | 9.39% |
| Q1 2016 | -8.92% |